Demand for new lab space has plummeted by more than half since the end of 2021, and life science vacancy rates are the highest they’ve been in a decade amid the biotech industry’s ongoing downturn, ...

The age of biotechnology is here. Products across a broad range of markets are made with biology, and conscious consumers demand a level of sustainability that only biomanufacturing can provide. The ...

NATICK — In a small lab space off Route 9, a group of scientists is working on a product that could change the agriculture industry. Ajay Arya, a senior scientist and soil microbiologist, explained ...

In many of the premier life science markets, developers are regularly acquiring office buildings and converting them to lab spaces. However, all buildings are not created equal, and while many have ...

When you think of life sciences and biotech hubs in the U.S., where do you travel to in your mind? Boston? The Bay Area? Texas? Portal Innovations, a biotech VC firm based in Chicago, is trying to ...

When Crystal Shih Byers left her job at Novartis in 2020, she was excited to make the leap into a smaller startup. Byers had spent almost nine years at Novartis, most recently helping lead a group ...

Boston Business Journal biotech reporter Hannah Green moderates a discussion with panelists from left: Gabriel Cavazos, Senior Managing Director, Biotechnology, Leerink Partner;, Dr. Harith ...

The recent National Institutes of Health funding cuts and proposed caps on indirect costs are raising concerns not only about the future of scientific innovation but also about potential economic ...

Westchester County's life science industry has been growing for decades, thanks to the county's proximity to New York City, its assets in health care, access to a varied workforce and more. But future ...

Moorpark College is opening a new biotechnology analytical lab prior to the launch of the school's first bachelor's degree program, in applied biomanufacturing, next month. Elected officials have been ...

BioAge Labs ( BIOA +1.02%) is a small drugmaker whose shares have caught fire this year. The company has made clinical ...